In the fiscal year 2021, Japanese pharmaceutical companies spent around 10.06 percent of sales on research and development (R&D), down from around 12 percent in fiscal 2015. Pharmaceutical companies in Japan spent a total of around 1.4 trillion Japanese yen on R&D in fiscal 2021.
Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Japan
Overview
4
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2021, by region
- Premium Statistic Number of medical drug manufacturing plants Japan 2021, by production value
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2021
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2021
Production
5
- Premium Statistic Production value of pharmaceutical drugs Japan 2012-2021
- Premium Statistic Share of drug production value Japan 2012-2021, by type
- Premium Statistic Share of drug production value Japan 2021, by category
- Premium Statistic Share of drug production value Japan 2021, by drug form
- Premium Statistic Production value of prescription drugs Japan 2012-2021
International trade
4
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2012-2021
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2012-2021
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2021, by region
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2021, by region
Sales
5
- Premium Statistic Prescription and OTC drug wholesales share in Japan FY 1990-2020
- Premium Statistic Prescription drug market size Japan 2002-2021
- Premium Statistic Share of prescription drug sales Japan FY 2011-2020, by channel
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Sales value of leading drugs Japan FY 2021
Expenditure
4
- Premium Statistic R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2021
- Premium Statistic R&D spending of pharmaceutical companies Japan FY 2015-2021
- Premium Statistic R&D expenditure of leading pharmaceutical manufacturers Japan 2020
- Premium Statistic Ad expenses of the pharmaceuticals industry Japan 2012-2021
Approval and patent
5
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2020, by type
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2020, by type
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2020
- Premium Statistic Number of patents in the pharmaceutical industry Japan 2021, by type
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2021
Leading companies
6
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2021, by distributor
- Premium Statistic Net sales of leading generics makers Japan 2020
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Basic Statistic Otsuka Holdings' net sales FY 2012-2021
- Basic Statistic Astellas Pharma's revenue FY 2012-2021
- Basic Statistic Daiichi Sankyo's revenue FY 2012-2021
Coronavirus (COVID-19)
3
Further related statistics
13
- Pharmaceutical sector expenditure forecast worldwide by country 2060
- Average CAGR of pharmaceutical spending in Asia 2013-2017, by country
- Pharmaceutical sector growth worldwide 2017-2030, by country
- Italy: pharmaceutical expenditure covered by the NHS 2012-2017
- Pharmaceutical sector growth worldwide 2017-2060, by country
- Pharmaceutical sector expenditures worldwide forecast by country 2017
- R&D spending by top Indian pharmaceutical companies India FY 2020
- Share for Italy of pharmaceuticals in EU market 2014-2018, by type of medication
- Value of exports of basic pharmaceutical products from Italy 2019, by macro-region
- Italy: public pharmaceutical expenditure in 2016, by ATC
- Global medicines spending share by product type forecast 2027
- Value of imports of basic pharmaceutical products into Italy 2019, by macro-region
- Total revenue of the French drug market worldwide 2010-2018
Further Content: You might find this interesting as well
Statistics
- Pharmaceutical sector expenditure forecast worldwide by country 2060
- Average CAGR of pharmaceutical spending in Asia 2013-2017, by country
- Pharmaceutical sector growth worldwide 2017-2030, by country
- Italy: pharmaceutical expenditure covered by the NHS 2012-2017
- Pharmaceutical sector growth worldwide 2017-2060, by country
- Pharmaceutical sector expenditures worldwide forecast by country 2017
- R&D spending by top Indian pharmaceutical companies India FY 2020
- Share for Italy of pharmaceuticals in EU market 2014-2018, by type of medication
- Value of exports of basic pharmaceutical products from Italy 2019, by macro-region
- Italy: public pharmaceutical expenditure in 2016, by ATC
- Global medicines spending share by product type forecast 2027
- Value of imports of basic pharmaceutical products into Italy 2019, by macro-region
- Total revenue of the French drug market worldwide 2010-2018
Ministry of Internal Affairs and Communications (Japan). (December 16, 2022). Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021 [Graph]. In Statista. Retrieved March 30, 2023, from https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/
Ministry of Internal Affairs and Communications (Japan). "Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021." Chart. December 16, 2022. Statista. Accessed March 30, 2023. https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/
Ministry of Internal Affairs and Communications (Japan). (2022). Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021. Statista. Statista Inc.. Accessed: March 30, 2023. https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/
Ministry of Internal Affairs and Communications (Japan). "Research and Development (R&d) Expenditure as a Share of Sales of Pharmaceutical Manufacturing Companies in Japan from Fiscal Year 2015 to 2021." Statista, Statista Inc., 16 Dec 2022, https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/
Ministry of Internal Affairs and Communications (Japan), Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021 Statista, https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/ (last visited March 30, 2023)
Research and development (R&D) expenditure as a share of sales of pharmaceutical manufacturing companies in Japan from fiscal year 2015 to 2021 [Graph], Ministry of Internal Affairs and Communications (Japan), December 16, 2022. [Online]. Available: https://www.statista.com/statistics/827477/japan-randd-spend-to-sales-pharna-industry/